The project “Understanding transfersomes’ structure to conquer (trans)dermal drug delivery” was approved under the 2022-I call of ALBA synchrotron.
The funded project on transfersomes aims to be a step forward toward the rational design of effective nanocarriers for (trans)dermal applications. Within the framework of the project, CBIOS researchers and PhD students will have the opportunity to perform X-ray scattering experiments in the synchrotron light facility of Barcelona. This proposal was funded under the 2022-I call of ALBA synchrotron.